Results 141 to 150 of about 179,889 (354)

Integration of patient-reported outcome measures with key clinical outcomes after immediate latissimus dorsi breast reconstruction and adjuvant treatment

, 2013
Background: linical evidence on patient-reported outcome measures (PROMS) in breast reconstruction is lacking. The aim of this study was to evaluate PROMs in implant-assisted latissimus dorsi (LDI) or tissue-only autologous latissimus dorsi (ALD) flap ...
Balta, V, Benson, J, Betambeau, N, Haviland, J, Prospective Trial Management, Grp, Reece-Smith, A, Winters, Z. E   +6 more
core   +1 more source

Body mass index as a predictive factor for efficacy of adjuvant taxane‐based chemotherapy in early‐stage breast cancer patients: A pooled analysis from adjuvant GEICAM Spanish Breast Cancer Group and TRIO Translational Research in Oncology Group studies

International Journal of Cancer, Volume 157, Issue 4, Page 709-721, 15 August 2025.
What's new? Body mass index (BMI) potentially influences outcomes among women with early‐stage breast cancer (EBC). Little is known, however, about relationships between BMI and disease prognosis for different adjuvant taxane‐based chemotherapies. Here, the prognostic effect of BMI on disease recurrence was evaluated among EBC patients treated with ...
José A. García‐Saenz, Gonzalo Spera, Marina Pollán, Begoña Bermejo, Manuel Ruiz‐Borrego, Arlene Chan, Miguel Martín, Ángel Guerrero‐Zotano, Lourdes Calvo, Álvaro Rodríguez‐Lescure, María Marín, Linnea Chap, John Crown, Tadeusz Pienkowski, Valerie Bee, Maribel Casas, Óscar Polonio, Susana Bezares, Dennis Slamon   +18 more
wiley   +1 more source

Beyond Mastectomy: The Incidence of Subsequent Aesthetic Procedures after Mastectomy with and without Breast Reconstruction

Plastic and Reconstructive Surgery, Global Open
Background:. Mastectomy poses significant challenges to a woman’s body image and psychological well-being, and breast reconstruction plays a pivotal role in postoperative quality of life.
Elizabeth S. O’Neill, MD, MPH, John A. Toms, III, MS, Marek A. Hansdorfer, MD, MS, George Kokosis, MD   +3 more
doaj   +1 more source

THE EFFECT OF LANGUAGE BARRIERS ON VARIATION AND RECEIPT OF EARLY STAGE BREAST CANCER TREATMENT

, 2020
Background: Arriving at and implementing an appropriate patient centered treatment plan for early stage breast cancer requires significant dialogue between healthcare providers and patients.
Madans, Abigail R, DO, Nygaard, Rachel M, PhD, Zera, Richard T, MD, PhD   +2 more
core  

Radical mastectomy versus radical mastectomy plus internal mammary dissection. Five-year results of an international cooperative study [PDF]

, 1976
J.‐P. Lacour, P. Bucalossi, E. Cacers, G Jacobelli, T Koszarowski, Monique G. Lê, C Rumeau‐Rouquette, Umberto Veronesi   +7 more
openalex   +1 more source

The TESTBREAST journey: Revisiting the importance of early detection by frequent screening of women at high risk of breast cancer

International Journal of Cancer, Volume 157, Issue 4, Page 741-751, 15 August 2025.
What's new? Women who are at high risk of breast cancer (BC), either because of a BRCA1/2 mutation or family history, require more aggressive screening. Here, the authors report on the clinical characteristics of the high‐risk women who developed BC during the TESTBREAST study. Of the 1108 participants, 124 (16.5%) developed breast cancer. Their median
Layla Andour, Sophie C. Hagenaars, Kiki Vangangelt, Janneke Aalberts, Valerie Rebattu, Dorien M. A. Berends van der Meer, Elma Meershoek‐Klein Kranenbarg, Katja N. Gaarenstroom, Christi J. van Asperen, Rob A. E. M. Tollenaar, Wilma E. Mesker, on behalf of the TESTBREAST study team, J. Aalberts, T. M. A. Berends‐van der Meer, S. C. Hagenaars, L. Andour, W.E. Mesker, R. A. E. M Tollenaar, W. M. Meershoek‐Klein Kranenbarg, K. N. Gaarenstroom, C. M. R. Haekens, K. B. M. I. Keymeulen, J. Remmelzwaal, M. Piek‐den Hartog, E. J. T. Rutgers, C. Drukker, C. Lemstra, A. Prozee, J. de Vries, A. Stam, C. Bandel, I. Meijer, A. E. Dassen, S. Makineli, E. E. van Oers‐Hazelzet, A. J. Witkamp, K. E. Schenk, W. van der Eijk, M. B. E. Menke‐Pluijmers, J. de Droog‐Laane, B. A. Kortmann   +40 more
wiley   +1 more source

NRG Oncology-Radiation Therapy Oncology Group Study 1014: 1-Year Toxicity Report From a Phase 2 Study of Repeat Breast-Preserving Surgery and 3-Dimensional Conformal Partial-Breast Reirradiation for In-Breast Recurrence. [PDF]

, 2017
PURPOSE: To determine the associated toxicity, tolerance, and safety of partial-breast reirradiation. METHODS AND MATERIALS: Eligibility criteria included in-breast recurrence occurring \u3e1 year after whole-breast irradiation, \u3c3 \u3ecm, unifocal ...
Arthur, Douglas W., Brown, Doris R., Canaday, Daniel J., Cohen, Randi J., Currey, Adam D., Cuttino, Laurie W., Fisher, Christine M., Haffty, Bruce G., Hayes, Shelly B., Jagsi, Reshma, Kuerer, Henry M., McCormick, Beryl, Sahijdak, Walter M., Simone, Nicole L., Todor, Dorin A., White, Julia, Winter, Kathryn A., Woodward, Wendy A.   +17 more
core   +1 more source

Bone metastases from breast cancer at the time of radical mastectomy as detected by bone scan.Eight-year follow-up [PDF]

, 1976
Robert B. Sklaroff, David M. Sklaroff
openalex   +1 more source

The Identification of Novel Prognostic and Predictive Biomarkers in Breast Cancer via the Elucidation of Tumor Ecotypes Using Ecotyper

Cancer Innovation, Volume 4, Issue 4, August 2025.
A novel breast cancer subtyping based on intra‐tumoral microenvironment heterogeneity predicts prognosis and immunotherapy response. The CE2 subtype, in particular, is linked to the worst outcomes and the most significant immunotherapy benefits, with distinct cellular and molecular features mediated by hypoxia.
Feng Du, Jie Ju, Fangchao Zheng, Songlin Gao, Peng Yuan   +4 more
wiley   +1 more source